Alcohol and Drug Foundation (Australia), April 27th 2020 There are now new challenges for people who access opioid replacement therapy (ORT) due to the COVID-19 (coronavirus) pandemic. Many may be experiencing anxiety and fear due to COVID-19 and trying to reduce and mitigate these feelings is vital. In most cases, people who are on ORT are required to visit their health clinic or pharmacy on a...
Hepatitis SA, May 2020 Hepatitis SA currently have a collection of hepatitis/liver related COVID-19 resources available online through their library catalogue. Hepatitis SA maintains a specialist library of physical and online resources; including books, reports, audio-visual resources, journals and newsletters, with the services of a professional librarian. Find the COVID-19 information here ...
International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019) Nearly 200 pages of open access articles from projects and research around the world. While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where...
infohep, Published:12 June 2018 The reduction in new hepatitis C virus (HCV) infections that has taken place in Scotland since 2008 is most likely due to increased provision of needle and syringe programmes and opioid substitution therapy, rather than a reduction in the number of people with hepatitis C as a result of increased treatment of HCV infection, a modelling study published in the...
6th International Symposium on Hepatitis Care in Substance Users, 6th Sept 2017 An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them. “The number of people around the world dying from hepatitis C is increasing. We have the tools to...